Unified Threat Management Market Size Worth $ 10.09 Billion By 2025: Grand View Research Inc.

San Francisco, 27 February 2020: The Report Unified Threat Management Market Size, Share & Trends Analysis Report By End Use (Telecom & IT, BFSI), By Component (Hardware, Virtual), By Enterprise Size (SME), By Service, By Deployment, And Segment Forecasts, 2019 – 2025

The global unified threat management market size is expected to reach USD 10.09 billion by 2025 at a CAGR of 14.5% from 2019 to 2025, according to a new study conducted by Grand View Research, Inc. Unified threat management (UTM) solutions eliminate the need for enhanced technical support and require fewer updates and contracts to manage network. This helps the end users to increase IT staff productivity and minimize operational costs. Latest trends, such as Bring-Your-Own-Device (BYOD), web applications, and virtualization, have compelled enterprises to prepare for emerging security risks in their networks, in addition to the growing concerns of internal and external threats. Growing number of such threats is impelling enterprises to adopt UTM solutions.

Moreover, these solutions are cost-effective and also have the ability to perform application-aware network tracking, scanning, and control. In addition, the solutions are easy to install & maintain and require lesser human intervention, which leads to further reduction in operational costs. All these factors are expected to drive the UTM market over the forecast period. Moreover, these solutions have multiple functionalities that allow consumers to reduce energy consumption and space. These benefits are further expected to contribute to the market growth. The key companies in the UTM market are focusing on developing advanced solutions that are aligned with the requirements of end users.

Access Research Report of Unified Threat Management Market @ https://www.grandviewresearch.com/industry-analysis/unified-threat-management-utm-market

Further key findings from the study suggest:

• Virtual component segment is anticipated to register the highest CAGR of 15.2% from 2019 to 2025 due to increasing number of SMEs requiring virtual infrastructure to securely run a wide range of applications
• Managed UTM segment is anticipated to register significant growth over the forecast period as these solutions eliminate the need to buy multiple appliances for enterprises and offer complete network protection
• The cloud segment is projected to expand at the highest CAGR during the estimated period. It is the most preferred deployment method of UTM solutions as it allows users to remotely manage the appliance
• Large enterprise is projected to be the fastest-growing segment from 2019 to 2025 due to increasing adoption of UTM solutions, which are cost-effective and easy to install & maintain in large enterprises
• BFSI segment is expected to register a significant growth in future. High demand for remotely managing security system, owing to increasing number of online hacks and cyberattacks in banks, is expected to drive the segment
• North America is expected to continue to dominate the global UTM market over the forecast period owing to the presence of major companies in the region
• Prominent industry participants include Barracuda Networks, Inc.; Cisco Systems, Inc.; Check Point Software Technologies Ltd.; SonicWall; Fortinet, Inc.; Huawei Technologies Co., Ltd.; Untangle, Inc.; Juniper Networks, Inc.; Sophos Ltd.; and WatchGuard Technologies, Inc.

Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/network-security-software-and-services

Grand View Research has segmented the global UTM market on the basis of component, service, deployment, enterprise size, end use, and region:

UTM Component Outlook (Revenue, USD Million, 2014 – 2025)

• Hardware
• Software
• Virtual

UTM Service Outlook (Revenue, USD Million, 2014 – 2025)

• Consulting
• Support & Maintenance
• Managed UTM

UTM Deployment Outlook (Revenue, USD Million, 2014 – 2025)

• Cloud
• On-premise

UTM Enterprise Size Outlook (Revenue, USD Million, 2014 – 2025)

• Large Enterprise
• Small & Medium Enterprise (SME)

UTM End Use Outlook (Revenue, USD Million, 2014 – 2025)

• BFSI
• Government
• Healthcare
• Manufacturing
• Retail
• Telecom & IT
• Others

UTM Regional Outlook (Revenue, USD Million, 2014 – 2025)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Access Press Release of Unified Threat Management Market @ https://www.grandviewresearch.com/press-release/global-unified-threat-management-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

 

Metrology Services Market Presenting A CAGR Of 5.9% Through 2025: Grand View Research Inc.

San Francisco, 27 February 2020: The Report Metrology Services Market Size, Share & Trends Analysis Report By Product (CMM & ODS), By Application (Automotive, Aerospace, Industrial), By Region, And Segment Forecasts, 2019 – 2025

The global metrology services market size is expected to reach USD 939.3 million by 2025, at a CAGR of 5.9% over the forecast period, according to a study conducted by Grand View Research, Inc. Increasing adherence to international quality standards in end-use industries and the need for the development of technologically advanced metrology software packages are expected to drive the growth. Moreover, steady growth in the local markets and surge in the aerospace and defense industries across emerging economies, such as China, India, Japan, Russia, Brazil, and South Korea is also anticipated to fuel the demand for metrology services.

Coordinate Measuring Machine (CMM) product provides precise measurement of the object for testing, assembling, design, profiling, and reverse engineering of parts. Therefore, increasing demand for services such as calibration, machine installation, and retrofitting offered by CMM is expected to drive the growth. Increasing demand for metrology services from different applications such as manufacturing, automotive, and power generation among others is projcted to continue driving the market growth over the forecast period.

Metrology services play a vital role across different industrial applications ranging from mining and heavy industrial production, fabrication, refineries, and material analysis. These services are primarily used for crack and failure analysis, grain sizing, cast iron modulatory and flake analysis, and surface analysis application. Different laser scanners are used in this industrial metrology services for precision measurement of a customized component, 3D CAD for inspection of molds and assemblies, laser tracker and large volume scanning for high accuracy, and better quality product output.

Asia Pacific is expected to be the prominent region over the forecast period. China led the region in 2018 as it is among the leading producers of iron, steel, chemical, consumer product, food processing, and transportation equipment manufacturing among others. On the other hand, U.S. led the North America metrology services market in 2018 owing to its extensive application across energy and power generation industry for raw casting, forging inspection, die and mold design and to inspect, repair or modify power generation turbine components. These technological advancements are expected to fuel the regional demand in near future.

Access Research Report of Metrology Services Market @ https://www.grandviewresearch.com/industry-analysis/metrology-services-market

Further key findings from the study suggest:

• North America ODS segment is expected to reach USD 183.6 million, at a CAGR of 5.7% by 2025. These services are explicitly used for reverse engineering operations in the manufacturing sector
• In Germany, the CMM segment is expected to reach USD 45.9 million by 2025, owing to increasing demand for services such as calibration, machine installation, and retrofitting, across various manufacturing industries
• The Asia Pacific automotive metrological services market is expected to reach USD 67.6 million by 2025, attributed to the increasing number of automotive component manufacturing facilities in the region

Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/electronic-devices

Grand View Research has segmented the global metrology services market on the basis of product, application, and region:

Metrology Services Product Outlook (Revenue, USD Million, 2015 – 2025)

• CMM
  • Gantry Machine
  • Bridge Machine
  • Articulated Arm Machine
  • Horizontal Arm Machine
• ODS
  • 3D Laser Scanner
  • White Light Scanner
  • Laser Tracker

Metrology Services Application Outlook (Revenue, USD Million, 2015 – 2025)

• Automotive
• Aerospace
• Industrial
• Power Generation
• Others

Metrology Services Regional Outlook (Revenue, USD Million, 2015 – 2025)

• North America
• Europe
• Asia Pacific
• RoW

Access Press Release of Metrology Services Market @ https://www.grandviewresearch.com/press-release/global-metrology-services-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

 

Amniotic Membrane Market Registering A 12.6% Through 2025: Grand View Research Inc.

San Francisco, 27 February 2020: The Report Amniotic Membrane Market Size, Share & Trends Analysis Report By End Use (ASC, Hospital), By Enzyme (Dehydrated, Cryopreserved), By Application (Ophthalmology, Surgical Wounds), And Segment Forecasts, 2018 – 2025

The global amniotic membrane market size is expected to reach USD 5.81 billion by 2025, according to a new report by Grand View Research, Inc. The market is estimated to witness a CAGR of 12.6% during the forecast period. Rise in trauma, burn cases and resulting surgeries along with increasing awareness regarding the benefits of these products are boosting the market growth. Rising number of cosmetic surgeries performed is also anticipated to drive the market during the forecast period. Amniotic membrane is also used in the treatment of a large number of ocular surface diseases as it protects surfaces from microbial colonization preventing the risk of infections.

Moreover, presence of growth factors including basic Fibroblast Growth Factor (bFGF), Transforming Growth Factors (TGFs), Epidermal Growth Factor (EGF), Vascular Endothelial Growth Factor (VEGF), Nerve Growth Factor (NGF), and Keratinocyte Growth Factor (KGF) in amniotic membranes promote wound healing, accelerating its adoption globally. Thus, its benefits, such as anti-inflammatory properties, reduced fibrosis and scarring at the site of surgery, pain reduction, and wound healing properties, are also fueling the demand. These products are thus most commonly used in surgeries, treatment of venous, pressure, and diabetic foot ulcers, ophthalmology, and in the management of chronic wounds.

The American Association of Tissue Banks is a non-profit organization that regulates tissue donation in U.S. Presence of such tissue banks ensures zero disease transmission, which, in turn, propels market growth. Furthermore, a number of institutes are trying to introduce novel areas of applications for these products by focusing on the research activities in stem cell and regenerative medicines. This factor is also likely to support market expansion. The use of cryopreserved amniotic membrane is largely seen in hospitals, Ambulatory Surgical Centers (ASCs), and specialty clinics. Lyophylization of the tissue post donation preserves the histological and biological activity of the tissue facilitating faster wound recovery.

Access Research Report of Amniotic Membrane Market @ https://www.grandviewresearch.com/industry-analysis/amniotic-membrane-market

Further key findings from the study suggest:

• Cryopreserved is expected to be the dominant segment in future as it’s highly effective and ensures preservation of histological and biological properties
• Surgical wounds segment is projected to witness high growth due to increasing usage of these products for surgical applications
• Specialty clinics are anticipated to register the highest CAGR during the forecast period due to increasing number of cosmetic and reconstructive surgeries being performed
• North America is a leading regional market owing to presence of a large number of key companies and high incidence of chronic and infectious diseases
• The Asia Pacific region is expected to record the highest CAGR during the forecast period due to growing population and rising incidence of chronic diseases and burn injuries
• Major companies in the amniotic membrane market include Alliqua BioMedical Inc.; Amnio Technology, Applied Biologics LLC; Human Regenerative Technologies DermaSciences; Katena Products, MiMedx Group Inc.; and Skye Biologics, Inc.

Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global amniotic membrane market on the basis of enzyme, application, end use, and region:

Amniotic Membrane Enzyme Outlook (Revenue, USD Million, 2014 – 2025)

• Cryopreserved Amniotic Membrane
• Dehydrated Amniotic Membrane

Amniotic Membrane Application Outlook (Revenue, USD Million, 2014 – 2025)

• Surgical Wounds
• Ophthalmology
• Others

Amniotic Membrane End Use Outlook (Revenue, USD Million, 2014 – 2025)

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Specialty Clinics
• Research and Academic Institutes

Amniotic Membrane Regional Outlook (Revenue, USD Million, 2014 – 2025)

• North America
• Europe
• Asia Pacific
• Latin America
• MEA

Access Press Release of Amniotic Membrane Market @ https://www.grandviewresearch.com/press-release/global-amniotic-membrane-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Capillary Blood Collection Devices Market Is Expected To Reach USD 1.75 Billion By 2025 : Grand View Research Inc.

San Francisco, 27 February 2020: The Report Capillary Blood Collection Devices Market Analysis Report By Material (Plastic, Glass, Stainless Steel), By Product, By Application (Whole Blood, Plasma Tests), By End Use, And Segment Forecasts, 2018 – 2025

The global capillary blood collection devices market size is expected to reach USD 1.75 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 5.4% during the forecast period. Increasing incidence of chronic, infectious and autoimmune diseases are some of the major factors propelling market growth owing to rising number of blood tests globally. Capillary blood draw technique has been most widely used for glucose and hemoglobin testing in clinics and hospitals. Ease of usage and minimally invasive nature also makes it ideal for home care diagnosis and testing, thereby boosting the market’s growth potential.The use of this technique in conjugation with PoC diagnostics has become the chosen mode of testing in remote and ambulatory health settings.

Blood gas detection, leukocyte & metabolite count, biomarker, nucleic acid, blood glucose, ferritin, lactate, effect of vitamin K-antagonist, and heavy metal ions analysis is commonly done using these samples. Thus, with rising adoption of rapid PoC diagnostics, usage of these devices is anticipated to increase in the near future.

Chronic diseases are a global healthcare problem with over half of the adult population in the U.S. suffering from chronic diseases, which contribute to over 75% of the total healthcare cost in the nation. Thus, rising number of infectious and chronic diseases creates a huge demand for diagnostic testing, thereby propelling growth of these collection devices.

Capillary blood draw technique is most often used in case of pediatric patients as it is difficult to draw venous and arterial blood from infants. Capillary blood draw is preferred in many ICU settings as patients lose large amount of blood during surgeries. Other blood drawing techniques are more invasive and might result in delays in the healing process or pose a risk of contamination. Ease of usage and effectiveness is another factor facilitating the use of these devices for home care diagnosis and testing, typically in case of diabetics.

Access Research Report of Capillary Blood Collection Devices Market @ www.grandviewresearch.com/industry-analysis/capillary-blood-collection-devices-market

Further Key Findings From the Report Suggest:

• Plastic devices held the largest market share in 2017 owing to their lightweight, cost-effective, and biocompatible nature coupled with extensive usage in medical devices
• Durability, non-porous nature, and impermeability are boosting the demand for glass devices
• Plastic and glass based collection devices are anticipated to dominate the market throughout the forecast horizon during the forecast period due to their extensive use in the manufacture of medical devices and other related products.
• North America will lead the market throughout the forecast period owing to existence of large number of major market players and high incidence of chronic and infectious diseases
• The Asia Pacific market is expected to rise at the highest CAGR during the same period. High population along with rising incidence of chronic diseases such as cancer and diabetes are the major factors contributing to the growth of the regional market
• Some of the major players are Becton, Dickinson and Company; NIPRO Europe Corporation; Sarstedt AG & Co; Thermo Fisher Scientific Inc.; Terumo Medical Corporation; B Braun Melsungen AG; Kabe Labortechnik GmbH; Greiner Bio One International GmbH; Cardinal Health; and Owen Mumford Ltd.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/clinical-diagnostics

Grand View Research has segmented the global capillary blood collection devices market on the basis of material, product, application, end use, and region:

Capillary Blood Collection Devices Material Outlook (Revenue, USD Million, 2014 – 2025)

• Plastic
• Glass
• Stainless Steel
• Ceramic
• Others

Capillary Blood Collection Devices Product Outlook (Revenue, USD Million, 2014 – 2025)

• Lancets
• Micro-Container Tubes
• Micro-Hematocrit Tubes
• Warming Devices
• Others

Capillary Blood Collection Devices Application Outlook (Revenue, USD Million, 2014 – 2025)

• Whole Blood
• Plasma/ Serum Protein Tests
• Comprehensive Metabolic Panel (CMP) Tests
• Liver Panel / Liver Profile/ Liver Function Tests
• Dried Blood Spot Tests

Capillary Blood Collection Devices End-Use Outlook (Revenue, USD Million, 2014 – 2025)

• Hospitals and Clinics
• Blood Donation Centers
• Diagnostic Centers
• Home Diagnosis
• Pathology Laboratories

Capillary Blood Collection Devices Regional Outlook (Revenue, USD Million, 2014 – 2025)

• North America
• Europe
• Asia Pacific
• Latin America
• MEA

Access Press Release of Capillary Blood Collection Devices Market @ www.grandviewresearch.com/press-release/global-capillary-blood-collection-devices-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Rosacea Treatment Market Registering A 6.8% CAGR Through The Forecast Period From 2019 To 2025: Grand View Research Inc.

San Francisco, 27 February 2020: The Report Rosacea Treatment Market Size, Share & Trends Analysis Report By Drug Class (Alpha Agonists, Antibiotics, Retinoids, Corticosteroids), By Mode of Administration (Topical, Oral), By Region, And Segment Forecasts, 2019 – 2025

The global rosacea treatment market size is expected to reach USD 2.6 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to register a CAGR of 6.8% over the forecast period. Several factors such as an advanced formulations and high prevalence of the disease are forecasted to fuel the market growth.

Rosacea affects more than 400 million people worldwide and the global incidence among adults is estimated at 5%. Less than 1.5 million patients seek treatment, making it a highly underdiagnosed condition. This disease has a higher incidence in women than men, with several studies claiming a possible association between rosacea and menopause. In the absence of an absolute cure, treatment options are largely focused on management of the disease.

The market for rosacea treatment is majorly genericized due to multiple patent expiries, leading to a highly fragmented therapeutic landscape. Rosacea is an underdiagnosed condition and is frequently misdiagnosed as acne. Off-label use of therapeutics pose an intensely competitive space for rosacea-specific treatments.

Topical therapies remain the mainstay for treatment. Topical products captured more than 60% market share in 2017. Although topical items are expected to maintain their lead over oral medicines through the forecast period, the market is witnessing a paradigm shift supported by the increasing inclination towards combination products.

Therapeutic options available for rosacea treatment are antibiotics, alpha agonists, retinoids, immunosuppressants, corticosteroids, antihypertensive agents, and others. Antibiotics are prescribed for the first-line treatment, making them the dominant drug class in 2017-a trend expected to continue through 2025.

The rosacea treatment market growth is supported by strong commercial sales from key products such as Rhofade, Mirvaso, Oracea, MetroGel, Noritate, and Finacea. Although increased penetration of generic drugs is a constraining factor, the impending launch of several promising pipeline products indicate an optimistic future for the global market.

Access Research Report of Rosacea Treatment Market @ https://www.grandviewresearch.com/industry-analysis/rosacea-treatment-market

Further key findings from the report suggest:

• The topical drugs segment held over 65% market share in 2017. These drugs are generally prescribed as first-line treatments and are preferred over other options in terms of convenience and results
• Alpha agonists is anticipated to be the fastest growing drug class, with a CAGR of over 8% during the forecast period
• Geographically, North America and Europe are the leading regions as the disease tends to affect people with fair/light skin. Asia Pacific is anticipated to witness the fastest growth owing to improved economic and healthcare scenario
• Key players operating in the rosacea treatment market include Bayer Schering AG; Bausch Health Companies Inc.; Foamix Pharmaceuticals; Nestlé S.A.; and Allergan Plc.

Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the global rosacea treatment market based on drug class, mode of administration, and region:

Rosacea Treatment Drug Class Outlook (Revenue, USD Million, 2014 – 2025)

• Antibiotics
• Alpha agonists
• Retinoids
• Corticosteroids
• Immunosuppressants
• Antihypertensive Agents
• Others

Rosacea Treatment Mode of Administration Outlook (Revenue, USD Million, 2014 – 2025)

• Topical
• Oral

Rosacea Treatment Regional Outlook (Revenue, USD Million, 2014 – 2025)

• North America
• Europe
• Latin America
• Asia Pacific
• Middle East & Africa

Access Press Release of Rosacea Treatment Market @ https://www.grandviewresearch.com/press-release/global-rosacea-treatment-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

U.S. Craniomaxillofacial (CMF) Devices/System Market Growing At USD 1.62 Billion By 2025 : Grand View Research Inc.

San Francisco, 27 February 2020: The Report U.S. Craniomaxillofacial (CMF) Devices/System Market Analysis Report By Material (Bioabsorbable, Metal), By Application, By Product (MF Plate, Temporomandibular Joint Replacement), And Segment Forecasts, 2018 – 2025

The U.S. craniomaxillofacial (CMF) devices/systems market size is poised to reach USD 1.62 billion by 2025, according to a new report by Grand View Research, Inc., rising at a CAGR of 6.9% during the forecast period. Increasing demand for cranial and facial surgeries is poised to drive the market over the forecast period.

Increasing incidence of sports injuries and road accidents due to industrialization and urbanization has also been providing an upthrust to the U.S. craniomaxillofacial devices market. According to the Wimbledon Clinics Report in 2015, kickboxing caused 2.5 facial injuries per hour and the rate was higher than other combat sports.

Access Research Report of U.S. Craniomaxillofacial (CMF) Devices/System Market @ https://www.grandviewresearch.com/industry-analysis/us-craniomaxillofacial-cmf-devices-system-market

Further key findings from the report suggest:

• Surging demand for minimally invasive surgeries is projected to boost the demand for craniomaxillofacial devices in the U.S. during the forecast period
• Temporomandibular joint replacement is anticipated to post the highest CAGR over the forecast period, owing to increasing incidence of trauma related to sports injuries and cranial fractures
• Metallic CMF implants accounted for the largest revenue share in 2017, owing to increasing use of metal 3D implants manufacturing
• Bioabsorbable material is estimated to register a lucrative CAGR of 7.3% during the same period due to ease with which they assimilate in human body. The other advantages include ability to transfer gradual load to healing tissues and radiolucency
• Plastic surgeries are expected to show steady growth during the same period, due to burgeoning popularity of the facial augmentation procedure and growing awareness regarding use of CMF devices. According to the American Society of Plastic Surgeons (ASPS), USD 16.0 billion were spent on cosmetic surgeries in 2016
• Favorable government policies supporting orthognathic surgeries are also likely to stoke the growth of the market
• Key companies operating in the U.S. craniomaxillofacial devices market are Stryker Corporation; Medtronic Plc; Zimmer-Biomet Inc.; and Medartis AG.

Browse more reports of this category by Grand View Research at:

Grand View Research has segmented the U.S. craniomaxillofacial devices market on the basis of product, material, and application:

U.S. Craniomaxillofacial Devices Product Outlook (Revenue, USD Million, 2014 – 2025)

• Cranial Flap Fixation
• CMF Distraction
• Temporomandibular joint replacement
• Thoracic fixation
• Bone Graft Substitute
• MF plate and screw fixation

U.S. Craniomaxillofacial Devices Material Outlook (Revenue, USD Million, 2014 – 2025)

• Metal
• Bioabsorbable material
• Ceramics

U.S. Craniomaxillofacial Devices Application Outlook (Revenue, USD Million, 2014 – 2025)

• Neurosurgery
• Orthognathic and Dental Surgery
• Plastic surgery

Access Press Release of U.S. Craniomaxillofacial (CMF) Devices/System Market @ https://www.grandviewresearch.com/press-release/us-craniomaxillofacial-cmf-devices-system-market-analysis

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Antibiotic Resistance Market Outlook And Industry Size To Reach USD 12.07 Billion By 2025: Grand View Research Inc.

San Francisco, 26 February 2020: The Report Antibiotic Resistance Market Size, Share & Trends Analysis Report By Disease (BSI, CDI, cUTI, cIAI), By Pathogen (E. coli, P. Aeruginosa, K. Pneumoniae), By Drug Class, and Segment Forecasts, 2018 – 2025

The global antibiotic resistance market size is estimated to reach USD 12.07 billion by 2025. According to a new report by Grand View Research, Inc., it is anticipated to post a CAGR of 5.6% during the forecast period. Rising burden of antibiotic-resistant infections and emergence of multi-drug resistant pathogens has been driving the market.

Biotech companies that are developing therapies for antibiotic-resistant infections include Melinta Therapeutics, Achaogen, and Nabriva Therapeutics. On the other hand, majority of large pharmaceutical companies don’t find this market lucrative enough due to slower growth in revenues for marketed drugs and lower return on investments. For instance, Novartis recently discontinued development of its antibacterial drugs for antibiotic resistance.

Manufacturers can obtain the Qualified Infectious Disease Product (QIDP) designation, which escalates the clinical review process for antibacterial therapies targeting high priority pathogens. The QIDP designation enables faster access to targeted agents and was introduced under the GAIN (Generating Antibiotic Incentives Now) Act, passed in 2012 as an extension to the U.S. FDA Safety and Innovation Act. The legislation aims to encourage the development of novel therapies for growing burden and severity of infections with antibiotic resistance.

Access Research Report of Antibiotic Resistance Market @ www.grandviewresearch.com/industry-analysis/antibiotic-resistance-market

Further key findings from the report suggest:

• In 2017, the market by cUTI disease registered significant sales due to elevated rate of resistance in extended-spectrum beta-lactamase (ESBL)-producing and carbapenem-resistant Enterobacteriaceae and P. aeruginosa strains
• The combination therapies segment, which includes fixed-dose combinations of beta lactams and beta lactamase inhibitors, is projected to witness the fastest growth rate over the forecast period
• Infections due to E. coli pathogens that are ESBL-producing and carbapenem-resistant led in terms of sales revenue in 2017 due to high treatment cost
• On the geographical front, North America was the dominant revenue contributor in the market in 2017. Improving reimbursement scenario with new technology add-on payment provision is promoting the use of novel products in this region
• Among pharmaceutical companies, Merck, Allergan, and Pfizer were the key players with top-selling drugs in the antibiotic resistance market in 2017.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the global antibiotic resistance market on the basis of disease, pathogen type, drug class, and region:

Antibiotic Resistance Disease Outlook (Revenue, USD Billion, 2014 – 2025)

• Complicated Urinary Tract Infection (cUTI)
• Complicated Intra-Abdominal Infections (cIAI)
• Blood Stream Infections (BSI)
• Clostridium difficile infections (CDI)
• Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
• Hospital Acquired Bacterial Pneumonia/Ventilator (HABP/VABP)
• Community Acquired Bacterial Pneumonia (CABP)

Antibiotic Resistance Pathogen Outlook (Revenue, USD Billion, 2014 – 2025)

• Acinetobacter baumannii (Carbapenem-Resistant)
• Pseudomonas aeruginosa (Carbapenem-Resistant)
• Staphylococcus Aureus
• coli/K. pneumoniae (Carbapenem-Resistant)
• Streptococcus pneumoniae (Penicillin-Non-Susceptible)
• Clostridium difficile (Cephalosporin-Resistant, Tetracycline-Resistant)
• Enterococcus faecium (Vancomycin-Resistant)
• Haemophilus Influenzae (Ampicillin-Resistant)

Antibiotic Resistance Drug Class Outlook (Revenue, USD Billion, 2014 – 2025)

• Oxazolidinones
• Lipoglycopeptides
• Tetracyclines
• Cephalosporins
• Combination
• Others

Antibiotic Resistance Regional Outlook (Revenue, USD Billion, 2014 – 2025)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Access Press Release of Antibiotic Resistance Market @ www.grandviewresearch.com/press-release/global-antibiotic-resistance-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

 

Cervical Cancer Treatment Market Is Expected To Reach USD 10.6 Billion By 2025 : Grand View Research Inc.

San Francisco, 26 February 2020: The Report Cervical Cancer Treatment Market Size, Share & Trends Analysis Report By Type (SCC, Adenocarcinoma), By Product (Prevention, Treatment), By Distribution Channel (Online, Hospital Pharmacies), And Segment Forecasts, 2018 – 2025

The global Cervical Cancer Treatment Market size is expected to reach USD 10.6 billion by 2025, according to a new report by Grand View Research, Inc. The market is projected to record a CAGR of 5.0% over the forecast period. Increased treatment penetration and rising disease incidence are projected to drive the market growth over the next few years. Although, sexually transmitted HPV is a major cause, the disease can also be triggered by other factors, such as oral contraceptives, multiple sexual partners, smoking, and HIV infection. There are more than 100 strains of HPV, 13 of which are high-risk or cancerous. Squamous cell carcinoma is the most common type and it accounts for nearly 85% of the overall cases.

The differentiation between squamous cell carcinoma and adenocarcinoma is based on the histology, as observed under the microscope. Cervical adenosquamous carcinoma is rare, involving a mixture of squamous and glandular tissues. Products for cervical cancer can be broadly classified into prevention and treatment. Preventive options involve vaccines against HPV. Currently, there are two commercial vaccines – Gardasil and Cervarix. Treatment options include biologics, such as Avastin and generics like topotecan, cisplatin, bleomycin, fluorouracil, paclitaxel, carboplatin, and doxorubicin. The development of targeted therapeutics with improved efficacy and reduced cost remains a key unmet need of this market. Nevertheless, expanding focus on the research and development in oncology, including cervical cancer, indicate a promising future for this market.

Access Research Report of Cervical Cancer Treatment Market @ www.grandviewresearch.com/industry-analysis/cervical-cancer-treatment-market

Further key findings from the study suggest:

• HPV affects nearly 95% of all cervical cancer cases. HPV strains 16 and 18 account for nearly 70% of all cases reported
• Nearly three-fourth of all cases occur in developing and underdeveloped regions (mostly, in Asia and Africa), where healthcare facilities are limited and awareness about diagnosis and treatment is low
• North America was the dominant region in the global cervical cancer treatment market and is expected to continue its dominance over the estimated period
• This growth is attributed to growing target population patient, increasing market penetration of drugs, and easy accessibility to advanced treatments
• Some of the key companies in the market include F. Hoffmann-LA Roche AG; Merck & Co., Inc.; GlaxoSmithKline PLC; Allergan PLC; Pfizer, Inc.; Biocon Ltd.; Bristol-Myers Squibb Company; AstraZeneca PLC; and Eli Lilly & Co.
• Merck & Co. led the competitive space and is likely to continue to be the largest shareholder due to strong commercial performances of Gardasil and Keytruda

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the global cervical cancer treatment market on the basis of type, product, distribution channel, and region:

Cervical Cancer Treatment Type Outlook (Revenue, USD Million, 2014 – 2025)

• Squamous Cell Carcinoma (SCC)
• Adenocarcinoma
• Adenosquamous Carcinoma

Cervical Cancer Treatment Product Outlook (Revenue, USD Million, 2014 – 2025)

• Prevention
  • Gardasil/Gardasil9
  • Cervarix
• Treatment
  • Avastin
  • Keytruda
  • Generics
  • Others

Cervical Cancer Treatment Distribution Channel Outlook (Revenue, USD Million, 2014 – 2025)

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Cervical Cancer Treatment Regional Outlook (Revenue, USD Million, 2014 – 2025)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Access Press Release of Cervical Cancer Treatment Market @ www.grandviewresearch.com/press-release/global-cervical-cancer-treatment-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

U.S. Depyrogenated Sterile Empty Vials Market Rising Size Is Likely To Reach USD 3.5 Billion By 2025: Grand View Research Inc.

San Francisco, 26 February 2020: The Report U.S. Depyrogenated Sterile Empty Vials Market Size, Share & Trends Analysis Report By Product (2 ml, 5 ml, 10 ml, 20 ml), By End Use (Clinical Labs, Componding Pharmacies), And Segment Forecasts, 2018 – 2025

The U.S. Dehydrogenated Sterile Empty Vials Market size is likely to reach USD 3.5 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 5.2% during the forecast period. Technological advancements in pharmaceutical packaging process, growing funding by government organizations, and flourishing biologics market in the U.S. are some of the key trends escalating market growth. Stringent regulations laid by the government for parenteral are also poised to augment the market.

Rising number of clinical labs in the country is resulting in an increased number of medical and diagnostic tests. This, in turn, is fueling the demand for depyrogenated sterile empty vials. Increasing number of compounding laboratories and research institutes in the U.S. is boosting the demand for these vials in the market. Moreover, continual growth in the pharmaceutical and biotechnology industry is further projected to drive the market.

Increasing number of collaborations in order to achieve innovative packaging technology is also providing an upthrust to the market. Rising incidence of infectious & non-infectious diseases and growing number of clinical studies are translating into a greater demand for these vials. Besides this, the government is backing the promotion of pharmaceutical, medical, and biotechnological researches, which is anticipated to work in favor of the market.

Access Research Report of U.S. Depyrogenated Sterile Empty VialsMarket @ www.grandviewresearch.com/industry-analysis/us-depyrogenated-sterile-empty-vials-market

Further key findings from the report suggest:

• More than 20 ml depyrogenated sterile empty vials emerged as the largest segment in terms of revenue in 2017 owing to rising incidence of infectious & non-infectious diseases and increasing investments in the biopharmaceutical sector
• Others, which include pharmaceutical manufacturers and academic & research institutes, formed the most prominent end-use segment in 2017. The growth of the segment can be attributed to expanding base of medical & biotech research institutes and upswing in pharmaceutical manufacturing
• Thermo Fisher Scientific, Inc.; Gerresheimer AG; SCHOTT AG; and DWK Life Sciences are the major players operating in the market. This market is considerably fragmented and market entry barrier is high.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the U.S. depyrogenated sterile empty vials market on the basis of product and end-use:

Depyrogenated Sterile Empty Vials Product Outlook (Revenue, USD Million, 2014 – 2025)

• 2 ml
• 5 ml
• 10 ml
• 20 ml
• More than 20 ml

Depyrogenated Sterile Empty Vials End-use Outlook (Revenue, USD Million, 2014 – 2025)

• Clinical Labs
• Compounding Labs
• Others

Access Press Release of U.S. Depyrogenated Sterile Empty VialsMarket @ www.grandviewresearch.com/press-release/us-depyrogenated-sterile-empty-vials-market-analysis

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Body Contouring Devices and Procedures Market Expected To Witness A Substantial Growth At A 13.8% Through 2025: Grand View Research Inc.

San Francisco, 26  February 2020: The Report Body Contouring Devices and Procedures Market Analysis Report By Device Type, By Procedure Type (Cellulite Treatment, Liposuction), By End Use, And Segment Forecasts, 2018 – 2025

The global body contouring devices market size is expected to reach USD 4.5 billion by 2025 at a 13.8% CAGR over the forecast period. The global body contouring procedures market size, on the other hand, is expected to value USD 9.3 billion by 2025, expanding at a CAGR of 7.7% from 2018 to 2025, according to a new report by Grand View Research, Inc, Increased awareness regarding noninvasive and minimally invasive body contouring procedures is expected to drive the devices market in next few years.

Aging baby boomers and introduction of advanced products by the market players are other drivers of the market. In addition, advantages associated with body contouring procedures is expected to augment the market growth. Body contouring procedures help remove excess body fat and significantly affect the person’s quality of life both functionally and aesthetically.

Entry of new products in developing region is likely to propel the market growth during the forecast period. For instance, in April 2018, Alma Lasers launched hands free body contouring solution, Accentuate, during Aesthetic & Anti-aging Medicine World Congress (AMWC) in Monaco.

Access Research Report of Body Contouring Devices and Procedures Market @ www.grandviewresearch.com/industry-analysis/body-contouring-devices-procedures-market

Further key findings from the study suggest:

• Improved accessibility to aesthetic procedures and enhanced safety due to minimally and noninvasive procedures are expected to drive the market
• Noninvasive devices segment accounted for the highest market share and is expected to maintain lucrative growth during the forecast period due to the advent of new devices
• Others segment is expected to observe the fastest growth due to technological advancement and noninvasive nature of these procedures. They also feature contact cooling technology that minimizes discomfort.
• Clinics and spa centers segment accounted for the highest market share due to the availability of technologically advanced devices and reduced risks of hospital-acquired infections
• North America accounted for the largest share of the body contouring devices market in 2017. The region is expected to maintain its dominance during the forecast period owing to the presence of major companies and availability of well-equipped aesthetic clinics and spa centers
• Some of the key companies in the global body contouring devices and procedure market are Cynosure, Inc.; Alma Lasers Ltd.; Allergan PLC; Syneron Medical Ltd.; Bausch Health Companies, Inc.; and Lumenis Ltd.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global body contouring devices and procedures markets on the basis of type, end use, and region:

Body Contouring Devices Type Outlook (Revenue, USD Million, 2014 – 2025)

• Noninvasive and Minimally Invasive Devices
• Invasive Devices

Body Contouring Procedure Outlook (Revenue, USD Million, 2014 – 2025)

• Nonsurgical Skin Resurfacing
• Nonsurgical Skin Tightening
• Cellulite Treatment
• Liposuction
• Others

Body Contouring Procedures End Use Outlook (Revenue, USD Million, 2014 – 2025)

• Hospitals
• Clinics and Spa Centers

Body Contouring Devices Regional Outlook (Revenue, USD Million, 2014 – 2025)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Body Contouring Procedures Regional Outlook (Revenue, USD Million, 2014 – 2025)

• U.S.
• Germany
• Spain
• Italy
• France
• U.K.
• Japan
• China
• India
• Brazil
• Mexico
• South Africa

Access Press Release of Body Contouring Devices and Procedures Market @ www.grandviewresearch.com/press-release/global-body-contouring-devices-procedures-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com